Background: Alopecia areata (AA) and psoriasis are associated with various psychiatric
comorbidities. Both greatly affect the quality of life (QOL) of patients and psychiatric …

Purpose Reactive oxygen species (ROS)-induced oxidative stress plays a key role in the
pathogenesis and progression of psoriasis by causing inflammation. Antioxidative strategies …

Psoriasis generally does not affect survival but has significant detrimental effect on quality of
life (QOL), which may be comparable to that of ischemic heart disease, diabetes …

Psoriasis is an inflammatory cutaneous disease mediated by T-cell dependent immune
responses; however, B cells are also considered to play an important role its development …

Psoriasis is an immune-mediated inflammatory disease (IMID) which may have a major
impact on a patient's life, especially when the disease is moderate to severe. There is …

Background Psoriasis and hidradenitis suppurativa (HS) exhibit distinct clinical features, but
no studies have directly compared the health-related quality of life (HRQoL) in patients with …

Background Psoriasis is an immune‐mediated, chronic, inflammatory skin disease which
affects approximately 2% of the world's population. It has a major impact on the patient's …

Background: Risk factors for psoriasis have been identified. Objective: To precisely define
these associated factors. Methods: A survey was conducted using a questionnaire on a …

Psoriasis and psoriatic arthritis (PsA) are chronic systemic inflammatory disorders with wide
spectrums of cutaneous and musculoskeletal presentations. Management of joint disease in …

Summary Background Adalimumab (ADA)(Humira®, AbbVie Inc., USA) is approved by the
European Medicines Agency for children aged≥ 4 years with severe plaque psoriasis …